Decreased expression of nociceptin/orphanin FQ in the dorsal anterior cingulate cortex of suicides

European Neuropsychopharmacology

Volumn 25, Issue 11, 2015, Pages 2008-2014

  Lutz, Pierre Eric ^a   Zhou, Yi ^a   Labbe, Aurélie ^a,b   Mechawar, Naguib ^a,b   Turecki, Gustavo ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Addiction; Anterior Cingulate Cortex; Depression; Nociceptin Opiod like Peptide receptor; Nociceptin Orphanin FQ; Suicide

Indexed keywords

NOCICEPTIN; NOCICEPTIN RECEPTOR; MESSENGER RNA; OPIATE PEPTIDE; OPIATE RECEPTOR; PREPRONOCICEPTIN; PROTEIN PRECURSOR;

ADULT; ANTERIOR INSULA; ARTICLE; DEPRESSION; DORSAL ANTERIOR CINGULATE CORTEX; FEMALE; GENE EXPRESSION REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBSTANCE ABUSE; SUICIDE; THALAMUS DORSOMEDIAL NUCLEUS; TIME OF DEATH; CINGULATE GYRUS; COMPARATIVE STUDY; METABOLISM; POLYMERASE CHAIN REACTION; THALAMUS;

ADULT; FEMALE; GYRUS CINGULI; HUMANS; MALE; MIDDLE AGED; OPIOID PEPTIDES; POLYMERASE CHAIN REACTION; PROTEIN PRECURSORS; RECEPTORS, OPIOID; RNA, MESSENGER; SUICIDE; THALAMUS;

EID: 84947484438     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.08.015     Document Type: Article

References (30)

1. Andero R., Brothers S.P., Jovanovic T., Chen Y.T., Salah-Uddin H., Cameron M., Bannister T.D., Almli L., Stevens J.S., Bradley B., Binder E.B., Wahlestedt C., Ressler K.J. Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD. Sci. Transl. Med. 2013, 5:188ra173.
2. Devine D.P., Hoversten M.T., Ueda Y., Akil H. Nociceptin/orphanin FQ content is decreased in forebrain neurones during acute stress. J. Neuroendocrinol. 2003, 15:69-74.
3. Dumais A., Lesage A.D., Alda M., Rouleau G., Dumont M., Chawky N., Roy M., Mann J.J., Benkelfat C., Turecki G. Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am. J. Psychiatry 2005, 162:2116-2124.
4. Etkin A., Egner T., Kalisch R. Emotional processing in anterior cingulate and medial prefrontal cortex. Trends Cogn. Sci. 2011, 15:85-93.
5. Gabilondo A.M., Meana J.J., Garcia-Sevilla J.A. Increased density of mu-opioid receptors in the postmortem brain of suicide victims. Brain Res. 1995, 682:245-250.
6. Gavioli E.C., Calo G. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs. Pharmacol. Ther. 2013, 140:10-25.
7. Gavioli E.C., Vaughan C.W., Marzola G., Guerrini R., Mitchell V.A., Zucchini S., De Lima T.C., Rae G.A., Salvadori S., Regoli D., Calo G. Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice. Naunyn Schmiedebergs Arch. Pharmacol. 2004, 369:547-553.
8. Goeldner C., Reiss D., Kieffer B.L., Ouagazzal A.M. Endogenous nociceptin/orphanin-FQ in the dorsal hippocampus facilitates despair-related behavior. Hippocampus 2010, 20:911-916.
9. Green M.K., Devine D.P. Nociceptin/orphanin FQ and NOP receptor gene regulation after acute or repeated social defeat stress. Neuropeptides 2009, 43:507-514.
10. Gross-Isseroff R., Dillon K.A., Israeli M., Biegon A. Regionally selective increases in mu opioid receptor density in the brains of suicide victims. Brain Res. 1990, 530:312-316.
11. Hurd Y.L. Subjects with major depression or bipolar disorder show reduction of prodynorphin mRNA expression in discrete nuclei of the amygdaloid complex. Mol. Psychiatry 2002, 7:75-81.
12. Jollant F., Bellivier F., Leboyer M., Astruc B., Torres S., Verdier R., Castelnau D., Malafosse A., Courtet P. Impaired decision making in suicide attempters. Am. J. Psychiatry 2005, 162:304-310.
13. Kennedy S.E., Koeppe R.A., Young E.A., Zubieta J.K. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Arch. Gen. Psychiatry 2006, 63:1199-1208.
14. Kuzmin, A., Bazov, I., Sheedy, D., Garrick, T., Harper, C., Bakalkin, G., 2009. Expression of pronociceptin and its receptor is downregulated in the brain of human alcoholics. Brain research 1305 Suppl, S80-85.
15. Lambert D.G. The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential. Nat. Rev. Drug Discov. 2008, 7:694-710.
16. Lohith T.G., Zoghbi S.S., Morse C.L., Araneta M.F., Barth V.N., Goebl N.A., Tauscher J.T., Pike V.W., Innis R.B., Fujita M. Brain and whole-body imaging of nociceptin/orphanin FQ peptide receptor in humans using the PET ligand 11C-NOP-1A. J. Nucl. Med. 2012, 53:385-392.
17. Mai J.K., Paxinos G., Voss T. Atlas of the Human Brain 2007, Elsevier Science. Third Edition.
18. Mallimo E.M., Kusnecov A.W. The role of orphanin FQ/nociceptin in neuroplasticity: relationship to stress, anxiety and neuroinflammation. Front. Cell Neurosci. 2013, 7:173.
19. Nativio P., Pascale E., Maffei A., Scaccianoce S., Passarelli F. Effect of stress on hippocampal nociceptin expression in the rat. Stress 2012, 15:378-384.
20. Nieuwenhuys R. The insular cortex: a review. Prog. Brain Res. 2012, 195:123-163.
21. Oquendo M.A., Sullivan G.M., Sudol K., Baca-Garcia E., Stanley B.H., Sublette M.E., Mann J.J. Toward a biosignature for suicide. Am. J. Psychiatry 2014, 171:1259-1277.
22. Pietrzak R.H., Naganawa M., Huang Y., Corsi-Travali S., Zheng M.Q., Stein M.B., Henry S., Lim K., Ropchan J., Lin S.F., Carson R.E., Neumeister A. Association of in vivo kappa-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathology. JAMA Psychiatry 2014, 71:1262-1270.
23. Redrobe J.P., Calo G., Regoli D., Quirion R. Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test. Naunyn Schmiedebergs Arch. Pharmacol. 2002, 365:164-167.
24. Ryan M.M., Lockstone H.E., Huffaker S.J., Wayland M.T., Webster M.J., Bahn S. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol. Psychiatry 2006, 11:965-978.
25. Scarr E., Money T.T., Pavey G., Neo J., Dean B. Mu opioid receptor availability in people with psychiatric disorders who died by suicide: a case control study. BMC Psychiatry 2012, 12:126.
26. Turecki G. The molecular bases of the suicidal brain. Nat. Rev. Neurosci 2014, 15:802-816.
27. Way B.M., Taylor S.E., Eisenberger N.I. Variation in the mu-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:15079-15084.
28. Willner P., Scheel-Kruger J., Belzung C. The neurobiology of depression and antidepressant action. Neurosci. Biobehav. Rev. 2013, 37:2331-2371.
29. Witkin J.M., Statnick M.A., Rorick-Kehn L.M., Pintar J.E., Ansonoff M., Chen Y., Tucker R.C., Ciccocioppo R. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence. Pharmacol Ther. 2014, 141:283-299.
30. Zollner C., Stein C. Opioids. Handb. Exp. Pharmacol. 2007, 31-63.